Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer. (Q39425368)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer. |
scientific article |
Statements
Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer (English)
Jessica D Sun
Qian Liu
Jingli Wang
Dharmendra Ahluwalia
Damien Ferraro
Yan Wang
Jian-Xin Duan
W Steve Ammons
John G Curd
Mark D Matteucci
19 December 2011